Vir Biotechnology Inc (VIR)

Operating return on assets (Operating ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	-517,588	-517,554	-485,694	-571,515	-662,405	-695,791	-314,095	-324,131	833,070	1,555,324	1,306,975	1,593,214	420,751	-259,405	-293,635	-383,703	-296,980	-252,335	-212,400	-219,118
Total assets	US$ in thousands	1,398,810	1,498,360	1,669,560	1,793,970	1,960,090	2,044,900	2,243,870	2,665,940	2,802,090	2,695,970	2,618,990	2,887,130	1,954,270	1,210,210	1,057,580	1,135,580	918,761	943,259	672,238	477,114
Operating ROA		-37.00%	-34.54%	-29.09%	-31.86%	-33.79%	-34.03%	-14.00%	-12.16%	29.73%	57.69%	49.90%	55.18%	21.53%	-21.43%	-27.76%	-33.79%	-32.32%	-26.75%	-31.60%	-45.93%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $-517,588K ÷ $1,398,810K
= -37.00%

The operating return on assets (operating ROA) of Vir Biotechnology Inc has displayed significant fluctuations over the quarters analyzed. Notably, the operating ROA started at negative levels in March 2020, indicating that the company had incurred operating losses relative to its assets. The negative trend continued throughout the first half of 2020, gradually improving but remaining in the negative territory.

By December 2021, there was a marked turnaround with a positive operating ROA of 21.53%, signifying that the company was generating operating income efficiently relative to its assets. This positive momentum continued into the following quarters of 2022, reaching its peak at 57.69% in September 2022.

However, the operating ROA experienced a sharp decline in the first quarter of 2023, falling to -12.16%, and remained in negative territory until the end of 2024. The negative operating ROA values in the latter part of the period suggest that the company's operating income was insufficient to cover the assets utilized in its operations.

Overall, the operating ROA trend indicates fluctuations in the company's operating efficiency and profitability, with periods of improvement followed by declines. Investors and stakeholders may want to monitor Vir Biotechnology Inc's operational performance closely to assess its ability to generate returns from its assets in the future.